Urgent Appeal for Treatment of B-Cell ALL Leukemia
Baby Arshin has been diagnosed with B-cell Acute Lymphoblastic Leukemia (ALL), a severe form of blood cancer. She is currently undergoing treatment at Bethany Hospital, requiring prolonged medical care, including intensive chemotherapy and supportive measures.
Treatment Plan:
The treatment involves:
- Intensive chemotherapy protocols
- Supportive care during and after chemotherapy
- Comprehensive pre- and post-treatment investigations
- Medications and consumables
- Doctor consultations and follow-ups
The treatment duration is expected to span approximately 2.5 years, requiring consistent medical care to ensure the best possible outcome.
The total cost for Baby Arshin’s treatment is approximately ₹20,00,000, covering admission, chemotherapy sessions, investigations, medications, and other hospital charges.
Arshin’s father is a daily wage laborer whose income is insufficient to cover the high costs of her treatment. The family is struggling to meet the financial demands of her care and is in urgent need of financial support.
Baby Arshin’s recovery and survival depend on timely and sustained treatment. Your support can help provide her with the life-saving care she urgently needs.
Your contribution, no matter the size, can make a tremendous difference in Arshin’s life. Please consider donating and sharing her story to help raise the necessary funds for her treatment.
Every donation brings Baby Arshin one step closer to recovery. Thank you for your kindness and generosity in supporting this little fighter’s journey toward health and happiness.
All donations made to Saaya Foundation are exempt under section 80G of the Income Tax Act. Registered ID : U85300MH2022NPL383369
Saaya Foundation, a National Registered Charity is raising funds for Baby Arshin
Saaya Foundation works in the areas of Medical Support, Women Empowerment, Child Rights, Social Awareness Programs, Protection from Domestic Violence, Health Initiatives, Personality Development Programs, Education, Natural Calamity Relief and other impact driven programs.
Comments